Remembering Gregg Allman: Understanding Liver Cancer

What was publicly reported

Gregg Allman was a singer, organist, and co-founder of the Allman Brothers Band. He died on May 27, 2017, at the age of 69. His longtime manager, Michael Lehman, told Variety that the cause was complications from liver cancer.

Variety's obituary sets out the sequence Allman had made public. He was diagnosed with hepatitis C in 2007. He learned he had liver cancer in 2008. He had a liver transplant at the Mayo Clinic in 2010, and he kept working afterward. Lehman said the cancer had come back about five years before Allman's death, and that Allman chose to keep that private.

That is what was disclosed. Everything else about his care was his own, and this page does not speculate about it.

The chain his story traces

Most liver cancer does not begin in a healthy liver. It begins in one that has been injured for years.

NCI's summary for clinicians describes the most common type in adults as hepatocellular carcinoma, or HCC. The risk factors it lists are:

• Long-term infection with hepatitis B or hepatitis C.
• Cirrhosis, meaning scar tissue replacing working liver tissue.
• Heavy alcohol use.
• Food contaminated with aflatoxin B1, a mold toxin.
• Nonalcoholic steatohepatitis, a fatty liver disease with inflammation.
• Tobacco use.
• Several inherited conditions, including hereditary hemochromatosis and Wilson disease.

The link matters because the first item on that list can be acted on. The USPSTF describes hepatitis C treatment as oral direct-acting antiviral regimens taken for 8 to 12 weeks, with high rates of sustained virologic response. NCI notes that vaccination lowers the risk of hepatitis B infection. Our page on hepatitis and liver cancer explains how the infection does its damage over decades.

Why this cancer is watched rather than screened

There is no general population screening test for liver cancer. There is something else: surveillance for people already known to be at high risk, usually because they have cirrhosis or chronic hepatitis.

NCI describes how that surveillance works in practice. A liver lesion under 1 cm found on imaging usually does not need immediate investigation, because most such spots are cirrhotic nodules rather than cancer. The common approach is to re-image every three months using the same technique.

For a lesion larger than 1 cm in someone at risk, the picture changes. NCI describes triple-phase contrast CT or MRI, which scans the liver in separate phases as contrast dye moves through it. HCC has its own signature on those scans: it lights up brightly in the arterial phase and then washes out. That pattern is distinctive enough that HCC is one of the few cancers that can sometimes be diagnosed on imaging alone, without a biopsy.

What treatment involves

Liver cancer is unusual in that two things have to be judged at once: the tumor, and how much working liver the person has left.

NCI notes that the standard TNM staging system has limited clinical use here precisely because it does not account for liver function. A small tumor in a badly scarred liver and the same tumor in a healthy liver are different problems.

Treatments with the intent to cure are transplant, surgical removal of part of the liver, and ablation, which destroys the tumor with heat or cold through a needle. NCI reports that only 10% to 23% of people with HCC are candidates for curative-intent surgery.

For those who are, the figures NCI reports are meaningfully better than the overall picture. Five-year overall survival after transplant for early HCC is 44% to 78%. After liver resection it is 27% to 70%. Those are wide ranges drawn from many studies, and they reflect carefully selected patients.

When to get checked

There is no useful list of early liver cancer symptoms, because early HCC usually causes none. The right trigger is risk, not symptoms.

Ask a clinician about hepatitis testing and liver surveillance if any of these apply:

• You are an adult aged 18 to 79 and have never been tested for hepatitis C. The U.S. Preventive Services Task Force recommends one-time screening for everyone in that age range, not only for people with obvious risk.
• You ever injected drugs, even once, decades ago.
• You have been told you have cirrhosis, fatty liver disease, or persistently abnormal liver blood tests.
• You drink heavily, or have done so for years.
• You have a family history of hemochromatosis or another inherited liver condition.

Get medical attention promptly for yellowing of the skin or eyes, a swollen belly, vomiting blood, or black tarry stools. Those are signs of advanced liver disease, not early cancer, and they need same-day assessment.

Our guide to alcohol and cancer covers the dose relationship, and liver cancer covers the disease in more depth.

The numbers, and what they leave out

The American Cancer Society projects about 42,340 new liver and intrahepatic bile duct cancer diagnoses in the United States in 2026, and about 30,980 deaths; SEER carries that projection. From SEER's own registry records, five-year relative survival across all stages was 21.9% for 2016 to 2022. About 45% of cases are found while still confined to the liver.

That is a group statistic covering everyone diagnosed over a span of years, under the treatments available then. It is not a prediction for any individual, and it averages across people with very different underlying liver health.

What this does not mean

• Hepatitis C does not mean liver cancer is coming. It raises risk over decades, and most people with the infection never develop it.
• A transplant is not a guarantee. Cancer can recur afterward, as Allman's manager said his did.
• No one can assign a cause in an individual case, and this page does not attempt to.
• One person's course, however public, is not a template for anyone else's.
• Nothing here is a reason to change treatment. That conversation belongs with a hepatologist or oncologist.

Sources

• Gregg Allman, Southern Rock Pioneer, Dies at 69 (Variety, May 27, 2017)
• NCI PDQ: Adult Primary Liver Cancer Treatment (Health Professional Version)
• SEER Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer
• USPSTF: Hepatitis C Virus Infection in Adolescents and Adults — Screening
• NCI: Infectious Agents and Cancer Risk

How this page was made

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.